We are live on ! Find out more
RWA

Ropes Wealth Advisors Portfolio holdings

AUM $515M
1-Year Est. Return 21.76%
This Fund
S&P 500
This Quarter Est. Return
+21.3%
1 Year Est. Return
+21.76%
3 Year Est. Return
+71.02%
5 Year Est. Return
+189.04%
10 Year Est. Return
AUM
$645M
AUM Growth
+$128M
Cap. Flow
+$30.6M
Cap. Flow %
4.75%
Top 10 Hldgs %
46.66%
Holding
961
New
341
Increased
188
Reduced
200
Closed
80

Top Buys

Rank Stock Value
1
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$7.07M
2
MRK icon
Merck
MRK
+$4.86M
3
MMM icon
3M
MMM
+$2.57M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$2.36M
5
IBM icon
IBM
IBM
+$2.03M

Sector Composition

Rank Sector Weight
1 Healthcare 34.43%
2 Technology 15.03%
3 Consumer Discretionary 6.53%
4 Industrials 6.47%
5 Financials 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIVE icon
601
Five Below
FIVE
$11.6B
$3K ﹤0.01%
16
-176
-92% -$26.1K
FLS icon
602
Flowserve
FLS
$8.94B
$3K ﹤0.01%
+89
New +$2.91K
FND icon
603
Floor & Decor
FND
$6.03B
$3K ﹤0.01%
32
-171
-84% -$14.3K
HOG icon
604
Harley-Davidson
HOG
$2.61B
$3K ﹤0.01%
+76
New +$2.61K
HYG icon
605
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$3K ﹤0.01%
40
-656
-94% -$56.2K
IEI icon
606
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$3K ﹤0.01%
+25
New +$3.32K
IRTC icon
607
iRhythm Holdings
IRTC
$4.02B
$3K ﹤0.01%
+12
New +$2.73K
LITE icon
608
Lumentum
LITE
$46.9B
$3K ﹤0.01%
+30
New +$2.59K
LQD icon
609
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$3K ﹤0.01%
+25
New +$3.4K
LRCX icon
610
Lam Research
LRCX
$316B
$3K ﹤0.01%
+60
New +$2.52K
MRVL icon
611
Marvell Technology
MRVL
$147B
$3K ﹤0.01%
+69
New +$2.99K
NOW icon
612
ServiceNow
NOW
$120B
$3K ﹤0.01%
+25
New +$2.6K
NTB icon
613
Bank of N.T. Butterfield & Son
NTB
$2.41B
$3K ﹤0.01%
100
SPGI icon
614
S&P Global
SPGI
$124B
$3K ﹤0.01%
+10
New +$3.37K
TRUP icon
615
Trupanion
TRUP
$1.13B
$3K ﹤0.01%
+28
New +$2.65K
VPL icon
616
Vanguard FTSE Pacific ETF
VPL
$7.77B
$3K ﹤0.01%
+32
New +$2.35K
VRNS icon
617
Varonis Systems
VRNS
$4.67B
$3K ﹤0.01%
+63
New +$2.73K
WST icon
618
West Pharmaceutical
WST
$23.7B
$3K ﹤0.01%
+9
New +$2.53K
ZYNE
619
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$3K ﹤0.01%
1,000
APEN
620
DELISTED
Apollo Endosurgery, Inc.
APEN
$3K ﹤0.01%
840
ATH
621
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$3K ﹤0.01%
+66
New +$2.61K
PFPT
622
DELISTED
Proofpoint, Inc.
PFPT
$3K ﹤0.01%
+20
New +$2.19K
BMY.RT
623
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$3K ﹤0.01%
4,182
-1,715
-29% -$3.65K
ADPT icon
624
Adaptive Biotechnologies
ADPT
$3.61B
$2K ﹤0.01%
+31
New +$1.6K
AGIO icon
625
Agios Pharmaceuticals
AGIO
$2.08B
$2K ﹤0.01%
+40
New +$1.58K

Similar funds

Ropes Wealth Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Ropes Wealth Advisors held 961 positions worth $645M, up 25% from $516M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Ropes Wealth Advisors deployed $30.6M of net new capital in Q4 2020, opening 341 new positions and adding to 188 existing holdings. Its largest new stake was Tractor Supply: 16,500 shares worth $464K.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Moderna, an estimated $1.95M trimmed.

  • Ropes Wealth Advisors's largest Q4 2020 buy was Tractor Supply: 16,500 shares worth $464K.
  • Ropes Wealth Advisors added most to iShares Core S&P Small-Cap ETF in Q4 2020, an estimated $7.07M increase.
  • Ropes Wealth Advisors's biggest Q4 2020 reduction was Moderna, cutting an estimated $1.95M.
  • Ropes Wealth Advisors fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $76K.
  • Ropes Wealth Advisors's ten largest holdings make up 47% of its $645M portfolio in Q4 2020.
  • Ropes Wealth Advisors opened 341 new positions and closed 80 in Q4 2020.
  • Ropes Wealth Advisors's portfolio value rose 25% quarter-over-quarter to $645M.

Based on Ropes Wealth Advisors's 13F filing for Q4 2020, filed 5 Feb 2021.